Bill Snyder

DNA sequence
October 31, 2013

VU ‘crosslinks’ study sheds light on chemical toxicity

Vanderbilt researchers have characterized the chemical structures of a series of DNA-protein “crosslinks” that may lead to better ways to avoid the cancer-causing potential of environmental chemicals and prevent some drug toxicities.

By Bill Snyder
October 24, 2013

Grad students help achieve key discovery

A multidisciplinary study conducted by the combined efforts of Vanderbilt University graduate students has led to the first evidence that abnormal messenger RNA export from the nucleus to the cytoplasm can cause human disease.

By Bill Snyder
October 24, 2013

Study sheds new light on type 2 diabetes development

Inactivation by oxidative stress of specific transcription factors essential for pancreatic islet beta cell function is a key event in the development of type 2 diabetes, Vanderbilt University researchers and their colleagues have found.

By Bill Snyder
VU banner with National Academies logo
October 21, 2013

Frisse, Weiner elected to Institute of Medicine

Vanderbilt University’s Betsy Weiner, Ph.D., R.N., senior associate dean for Informatics in the School of Nursing, and Mark Frisse, M.D., MS, MBA, Accenture Professor and director of Regional Informatics, have been elected to the Institute of Medicine (IOM), the organization announced this week.

By Bill Snyder
October 21, 2013

Institute of Medicine honors Vanderbilt’s Clayton

Ellen Wright Clayton, M.D., J.D., the Craig-Weaver Professor of Pediatrics and professor of Law at Vanderbilt University, has won the David Rall Medal from the Institute of Medicine (IOM) for “exemplary” service to the institute.

By Bill Snyder
October 17, 2013

Weill Cornell’s Glimcher awarded Vanderbilt Prize

The 2013 Vanderbilt Prize in Biomedical Science has been awarded to Laurie Glimcher, M.D., Stephen and Suzanne Weiss Dean and professor of Medicine at Weill Cornell Medical College in New York City.

By Bill Snyder
October 17, 2013

Synthetic biology expert Collins set to speak at Vanderbilt

Boston University biomedical engineer and MacArthur Fellow James Collins, Ph.D., will lecture at 3:10 p.m. Oct. 23 in the Jacobs Believed in Me Auditorium, part of the Vanderbilt School of Engineering’s Featheringill Hall.
By Bill Snyder
October 11, 2013

New target for stopping inflammation

Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases.
By Bill Snyder
October 10, 2013

Clinical and translational research highlighted at retreat

Kathleen Neuzil, M.D., MPH, known internationally for her efforts to expand vaccine access and delivery around the world, credited her Vanderbilt University mentors last week for guiding her to a career path that allowed her to “make a difference.”
By Bill Snyder
October 10, 2013

Discovery Lecturer makes case for stronger science

The occasional failings of science tend to draw big headlines — findings that can’t be replicated or increasing numbers of papers that are retracted because studies were improperly or even fraudulently conducted.
By Bill Snyder
October 3, 2013

VUMC poised to overcome health care challenges: Balser

While the national economy appears to be getting stronger, health care has entered a national recession, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the Vanderbilt University School of Medicine, told a packed audience of approximately 1,100 Vanderbilt faculty, staff and students in Langford Auditorium on Wednesday afternoon while making his annual State of the Medical Center address.
By Bill Snyder
September 26, 2013

VU’s technology commercialization efforts make strides

Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced.
By Bill Snyder
1 … 99 100 101 102 103 … 115